GS announces 277 positive COVID-19 cases after third week
August 31, 2021
Editor’s note: An earlier version of this article said 32 cases were reported by faculty. That was incorrect as this number includes faculty and staff as “employees”.
Georgia Southern saw a decrease in COVID-19 cases last week, announcing Monday 277 positive COVID-19 cases in the third week.
While case numbers are down from last week, GS had the most positive cases ever reported by university employees last week at 32 cases.
“Georgia Southern’s COVID-19 numbers are reflecting similar trends in the region, state and country. Recognizing that COVID-19 vaccines offer safe, effective protection, we continue to urge all students, faculty, staff and visitors to get vaccinated either on campus or with a local provider,” read a disclaimer above GS’ weekly report.
32 cases were reported from employees. 230 cases were reported on Statesboro’s campus, 43 on Armstrong’s campus and four on Liberty’s campus.
COVID-19 Analysis
- Total positive cases: 277
- University confirmed: 48
- Self reported: 229
- Students: 245
- Employees: 32
- Statesboro campus: 230
- Armstrong campus: 43
- Liberty campus: four
Jana Renz • Aug 31, 2021 at 8:57 am
I would like to thank you for your reporting of facts. I realize the official university policy is to promote and encourage vaccination for all. I only wish I had more faith in this vaccine.
RNA vaccines are the first ever of their kind and the do pose serious health risks for many, especially the risk of blood clotting. This is a recorded fact. It is also reported to cause a high number of miscarriages in women and may affect the reproductive organs in me. This is of great concern to our younger population. There are long term consequences that we still do not know.
The very idea that we would use the entire world population in this medical experiment is unconscionable. There are many good drugs that should be made available for the treatment of COVID. But they are NOT easily available because of the unbelievable amount of money to be made from worldwide vaccination.